Drug Design and Synthesis Core
- Institution
- University of South Carolina at Columbia, SC
- Principal investigator
- Campbell Mcinnes
- Funding
- $203K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
SUMMARY The Drug Design and Synthesis Core (DDSC) is key to the mission and overall success of the COBRE Center for Targeted Therapeutics (CTT) and made key contributions to the success of Phases 1 and 2. Its mission is to provide expertise to investigators in evaluation of biological targets for druggability, to assist them in synthesizing chemical analogs that can be used in drug development and furthermore in designing viable strategies for drug discovery and optimization. DDSC is the only chemical synthesis core facility operating at USC and provides unique services to interested investigators. In accomplishing the specific aims, the DDSC will enable investigators to maximize the funding potential and scientific outcomes of their research progress while leading to potential new therapeutic options for challenging diseases, conditions, and illnesses.
LOADING MOONBASE SCORE
Questions for University of South Carolina at Columbia
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Ppi Pharmaceuticals, LlcNot yet scored
Investigating Abbapolin PLK1 Polo Box Domain inhibitors as potential therapeutics for colorectal cancers
Campbell Mcinnes · $396K · 2025–2026
- NIH · University of South Carolina at Columbia66
Using Open-Source Technology to Measure Energy Expenditure and Sleep Among Children 3 to 8 Years Old
Bridget R. Armstrong · $722K · 2023–2028
- NSF · University of South Carolina at Columbia58
EAGER: NAIRR Pilot: Demonstrating a Compact Foundation Model for Planning-Like(PL) Tasks for Next Generation Trusted Applications
Biplav Srivastava · $300K · 2025–2027